Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 1.9B | 1.9B | 1.8B |
Cost of revenue | 1.4B | 1.4B | 1.4B | 1.3B |
Gross profit | 619M | 583M | 529M | 514M |
Operating expense | ||||
Research & development | 9M | 8M | 7M | 9M |
Selling general and admin | 96M | 85M | 92M | 85M |
Other operating expenses | — | — | — | — |
Operating income | 514M | 490M | 430M | 420M |
Non operating interest income | ||||
Income | 4M | 4M | 5M | 4M |
Expense | 38M | 39M | 40M | 44M |
Other income expense | -11M | -9M | -3M | -26M |
Pretax income | 469M | 446M | 392M | 354M |
Tax provision | 62M | 102M | 78M | 22M |
Net income | 407M | 344M | 314M | 332M |
Basic EPS | — | 0.9 | 0.8 | 0.8 |
Diluted EPS | — | 0.8 | 0.8 | 0.8 |
Basic average shares | — | 405M | 406M | 408M |
Diluted average shares | — | 407M | 408M | 410M |
EBITDA | 579M | 555M | 516M | 478M |
Net income from continuing op. | 407M | 344M | 314M | 332M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |